Home Newsfeeds Craig-Hallum Downgrades PLAYSTUDIOS to Hold

Craig-Hallum Downgrades PLAYSTUDIOS to Hold

Craig-Hallum analyst Ryan Sigdahl downgrades PLAYSTUDIOS (NASDAQ:MYPS) from Buy to Hold.

byBenzinga Newsdesk

July 11, 2022

1 minute read

Craig-Hallum analyst Ryan Sigdahl downgrades PLAYSTUDIOS (NASDAQ:MYPS) from Buy to Hold.

eFFECTOR Therapeutics Shares Jump After Clinical Update Of Investigational Cancer Drug

By Vandana Singh

January 6, 8:12 AM

eFFECTOR Therapeutics Inc (NASDAQ:EFTR) provided an update on its ongoing clinical development programs for zotatifin, in Phase 2 expansion cohorts for…

EFTR

News
Tech

The Other Apple CEO Steve Wozniak Is Thankful For (Hint: It’s Not Steve Jobs)

By Ananya Gairola

March 9, 4:06 AM

Apple Inc. (NASDAQ:AAPL) co-founder Steve Wozniak took to Twitter to “thank” a former CEO of the company —…

AAPL

Pioneer Power Announces e-Boost Orders Totaling $3.1M; Expands Placements In Utilities And Transportation Verticals

By Benzinga Newsdesk

December 19, 10:08 AM

Expands Placements in Utilities and Transportation VerticalsPioneer Power Solutions, Inc. (NASDAQ:PPSI) ("Pioneer", "Pioneer Power" or the "Company"), a leader in the design, manufacture, service and integration of

PPSI

ViaCyte Acquisition Can Accelerate Vertex’s Ongoing Type 1 Diabetes Programs

By Vandana Singh

July 11, 10:54 AM

Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has agreed to acquire ViaCyte, a privately held biotechnology, for $320 million in cash. ViaCyte is focused…

VRTX

Craig-Hallum Downgrades PLAYSTUDIOS to Hold

Related Posts

eFFECTOR Therapeutics Shares Jump After Clinical Update Of Investigational Cancer Drug

The Other Apple CEO Steve Wozniak Is Thankful For (Hint: It’s Not Steve Jobs)

Pioneer Power Announces e-Boost Orders Totaling $3.1M; Expands Placements In Utilities And Transportation Verticals

ViaCyte Acquisition Can Accelerate Vertex’s Ongoing Type 1 Diabetes Programs